Search Results for: johnson & johnson

The Mounting Case against Xarelto from FDA Direct Adverse Drug Reports

October 12, 2015 By US Recall News Leave a Comment

In just the last four years, the FDA has raised many separate clarifications with Johnson & Johnson about the blood thinning drug Xarelto. These have included extra black box warnings about the possible contraindications, additional advertising requirements and further possible side effects that were not included on the original FDA approval in … [Read more...]

The False Marketing of Risperdal

October 8, 2015 By US Recall News Leave a Comment

Risperdal has been licensed by the FDA since February 1994 for use in psychotic episodes, with a particular emphasis on schizophrenia. It is made by Johnson & Johnson, who most of us know from their range of consumer products, such as baby powder and Listerine mouthwash. However, what is less well known is that Johnson & Johnson make most … [Read more...]

Talcum Powder linked to Ovarian Cancer

September 16, 2015 By US Recall News Leave a Comment

Talcum powder has been a common household item for decades. You probably have some in your bathroom right now. What could be more benign than baby powder? Women used it as a feminine hygiene product for years before it was finally marketed as such. But talcum powder was linked to ovarian cancer as far back as the early 1970’s, and recent research … [Read more...]

Xarelto Dangers

April 25, 2015 By US Recall News Leave a Comment

Xarelto (rivaroxaban) is a popular anti-clotting drug that is prescribed as a more convenient option than older anti-coagulants such as warfarin. Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, tells consumers that Xarelto will free you from the routine blood monitoring necessary with older blood thinners and that it is the … [Read more...]

Stryker May Still Be In Denial When It Comes To Their Financial Exposure Related To Recalled Hips

April 11, 2013 By Jonathan Rosenfeld 4 Comments

In a press release to shareholders, Stryker estimated that the recall of its Rejuvenate and ABG II modular-neck hip replacements would cost between $190 million and $390 million but Stryker might be a little too optimistic for comfort. Johnson and Johnson has already spent $800 million on a similar recall and still faces litigation in over 10,000 … [Read more...]